These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2162129

  • 1. Middle molecular weight substances and uremic polyneuropathy.
    Dukanović L, Petrović J, Potić J.
    Acta Med Iugosl; 1990; 44(2):117-28. PubMed ID: 2162129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Middle molecular weight substances in the cerebrospinal fluid of uremic patients.
    Sperschneider H, Spustova V, Stein G, Dzurik R.
    Clin Nephrol; 1982 Jun; 17(6):298-302. PubMed ID: 7105504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical implications of uremic middle molecules in regular hemodialysis patients.
    Asaba H, Alvestrand A, Fürst P, Bergström J.
    Clin Nephrol; 1983 Apr; 19(4):179-87. PubMed ID: 6851254
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Examination of lymphokines in patients with hemodialysis (author's transl)].
    Löcsey L, Kálmán K, Hauck M, Kakuk G.
    Allerg Immunol (Leipz); 1979 Apr; 25(3):211-7. PubMed ID: 162030
    [Abstract] [Full Text] [Related]

  • 14. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A, Myśliwiec M, Soszka J.
    Pol Tyg Lek; 1979 Apr; 45(40-41):810-3. PubMed ID: 2096374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of alterations of uremic retention products upon platelet and peripheral nerve function.
    Lindsay RM, Bolton CF, Clark WF, Linton AL.
    Clin Nephrol; 1983 Mar; 19(3):110-5. PubMed ID: 6839559
    [Abstract] [Full Text] [Related]

  • 17. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981 Mar; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

  • 18. Uremic polyneuropathy.
    Pavlović D, Bobinac-Georgievski A.
    Clin Nephrol; 1991 Nov; 36(5):265-6. PubMed ID: 1661217
    [No Abstract] [Full Text] [Related]

  • 19. [Peripheral neuropathy in the uremic patient during periodic hemodialysis: clinical and electrophysiologic response to treatment with cerebral cortical gangliosides].
    Catizone L, Merlini L, Fusaroli M.
    Riv Neurobiol; 1978 Nov; 24(1-2):43-56. PubMed ID: 231816
    [No Abstract] [Full Text] [Related]

  • 20. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981 Nov; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.